- Home
- LVO vs IKNA Comparison
LVO vs IKNA Comparison
Compare LVO & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- IKNA
- Stock Information
- Founded
- LVO 2009
- IKNA 2016
- Country
- LVO United States
- IKNA United States
- Employees
- LVO N/A
- IKNA N/A
- Industry
- LVO Restaurants
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- IKNA Health Care
- Exchange
- LVO Nasdaq
- IKNA Nasdaq
- Market Cap
- LVO 61.3M
- IKNA 61.8M
- IPO Year
- LVO N/A
- IKNA 2021
- Fundamental
- Price
- LVO $0.72
- IKNA $1.13
- Analyst Decision
- LVO Strong Buy
- IKNA Buy
- Analyst Count
- LVO 1
- IKNA 2
- Target Price
- LVO $1.50
- IKNA $3.00
- AVG Volume (30 Days)
- LVO 391.1K
- IKNA 97.6K
- Earning Date
- LVO 05-29-2025
- IKNA 05-08-2025
- Dividend Yield
- LVO N/A
- IKNA N/A
- EPS Growth
- LVO N/A
- IKNA N/A
- EPS
- LVO N/A
- IKNA N/A
- Revenue
- LVO $126,016,000.00
- IKNA N/A
- Revenue This Year
- LVO $0.69
- IKNA N/A
- Revenue Next Year
- LVO N/A
- IKNA N/A
- P/E Ratio
- LVO N/A
- IKNA N/A
- Revenue Growth
- LVO 11.43
- IKNA N/A
- 52 Week Low
- LVO $0.55
- IKNA $0.97
- 52 Week High
- LVO $1.98
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- LVO 51.51
- IKNA 43.57
- Support Level
- LVO $0.67
- IKNA $1.22
- Resistance Level
- LVO $0.76
- IKNA $1.29
- Average True Range (ATR)
- LVO 0.09
- IKNA 0.09
- MACD
- LVO 0.01
- IKNA -0.01
- Stochastic Oscillator
- LVO 33.15
- IKNA 23.33
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.